Valneva (VALN)

• Market cap: $520M
• 1 day: -3.35%
• 5 days: -7.74%
• 1 month: 3.59%
• 3 months: -50.68%
• 6 months: -38.43%
• Year to date: -38.84%
• 1 year: -12.74%
• 5 years: -79.96%
• 10 years: -80.67%
• Sector: Healthcare
• Industry: Biotechnology

About: Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Employees: 674